FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kanti Rai

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Physiology

Mutation

Co-author Network

Publications

TOP 3
Jennifer A Woyach; Frederick R Appelbaum; Andrew R Belch; Susan Geyer; Jonathan Kolitz; Richard A Larson; Thomas S Lin; Vicki A Morrison; Kanti Rai; Amy S Ruppert; Martin S Tallman; John C Byrd
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.
Thomas S Lin; Kathleen A Donohue; John C Byrd; Margaret S Lucas; Eva E Hoke; Elizabeth M Bengtson; Kanti Rai; James N Atkins; Brian K Link; Richard A Larson
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
Charles C Chu; Rosa Catera; Lu Zhang; Sebastien Didier; Briana M Agagnina; Rajendra N Damle; Matthew Kaufman; Jonathan E Kolitz; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kanti Rai (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer A Woyach; Frederick R Appelbaum; Andrew R Belch; Susan Geyer; Jonathan Kolitz; Richard A Larson; Thomas S Lin; Vicki A Morrison; Kanti Rai; Amy S Ruppert; Martin S Tallman; John C Byrd
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(4):440-7.
2010: Thomas S Lin; Kathleen A Donohue; John C Byrd; Margaret S Lucas; Eva E Hoke; Elizabeth M Bengtson; Kanti Rai; James N Atkins; Brian K Link; Richard A Larson
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(29):4500-6.
2010: Charles C Chu; Rosa Catera; Lu Zhang; Sebastien Didier; Briana M Agagnina; Rajendra N Damle; Matthew Kaufman; Jonathan E Kolitz; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.
Blood 2010;115(19):3907-15.
2010: Matthew Kaufman; Kanti Rai
The challenge of treating complex autoimmune cytopenias in chronic lymphocytic leukemia.
Leukemia & lymphoma 2010;51(4):574-5.
2010: Kanti Rai
Where do we go from here?
Best practice & research. Clinical haematology 2010;23(1):167-8.
2010: Sylwia E Wojcik; Simona Rossi; Masayoshi Shimizu; Milena S Nicoloso; Amelia Cimmino; Hansjuerg Alder; Vlad Herlea; Laura Rassenti; Kanti Rai; Thomas J Kipps; Michael J Keating; Carlo M Croce; George A Calin
Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.
Carcinogenesis 2010;31(2):208-15.
2009: Carlo Calissano; Rajendra N Damle; Gregory Hayes; Elizabeth J Murphy; Marc K Hellerstein; Carol Moreno; Cristina Sison; Matthew Kaufman; Jonathan E Kolitz; Steven Allen; Kanti Rai; Nicholas Chiorazzi
In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.
Blood 2009;114(23):4832-42.
2009: Matthew Kaufman; Jason Rubin; Kanti Rai
Diagnosing and treating chronic lymphocytic leukemia in 2009.
Oncology (Williston Park, N.Y.) 2009;23(12):1030-7.
2009: Susan O'Brien; Joseph O Moore; Thomas E Boyd; Loree Larratt; Aleksander B Skotnicki; Benjamin Koziner; Asher Chanan-Khan; John F Seymour; John Gribben; Loretta M Itri; Kanti Rai
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5208-12.
2009: Anders Osterborg; R Foà; R F Bezares; C Dearden; M J S Dyer; Christian Hartmann Geisler; T S Lin; M Montillo; M H J van Oers; C-M Wendtner; Kanti Rai
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia.
Leukemia 2009;23(11):1980-8.
2009: Till Seiler; Manuela Woelfle; Sophia Yancopoulos; Rosa Catera; Wentian Li; Katerina Hatzi; Carol Moreno; Marcela Torres; Santanu Paul; Hartmut Dohner; Stephan Stilgenbauer; Matthew Kaufman; Jonathan E Kolitz; Steven Allen; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.
Blood 2009;114(17):3615-24.
2009: John C Byrd; Bercedis L Peterson; Kanti Rai; David Hurd; Raymond Hohl; Michael C Perry; Jon Gockerman; Sreenivasa Nattam; Richard A Larson
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.
Leukemia & lymphoma 2009;50(10):1589-96.
2009: Matthew Kaufman; Sewanti A Limaye; Nancy Driscoll; Christina Johnson; Angelica Caramanica; Yehuda Lebowicz; Dilip Patel; Nina Kohn; Kanti Rai
A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Leukemia & lymphoma 2009;50(6):892-9.
2009: Vladimir Grubor; Alexander Krasnitz; Jennifer E Troge; Jennifer L Meth; B Lakshmi; Jude T Kendall; Boris Yamrom; Garrick Alex; Deepa Pai; Nicholas Navin; Lisa A Hufnagel; Yoon-Ha Lee; Kerry Cook; Steven Allen; Kanti Rai; Rajendra N Damle; Carlo Calissano; Nicholas Chiorazzi; Michael Wigler; Diane Esposito
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA).
Blood 2009;113(6):1294-303.
2008: Charles C Chu; Rosa Catera; Katerina Hatzi; Joy (Xiao-Jie) Yan; Lu Zhang; Xiao Bo Wang; Henry M Fales; Steven Allen; Jonathan E Kolitz; Kanti Rai; Nicholas Chiorazzi
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.
Blood 2008;112(13):5122-9.
2008: Rosa Catera; Gregg J Silverman; Katerina Hatzi; Till Seiler; Sebastien Didier; Lu Zhang; Maxime Hervé; Eric Meffre; David G Oscier; Helen Vlassara; R Hal Scofield; Yifang Chen; Steven Allen; Jonathan Kolitz; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.
Molecular medicine (Cambridge, Mass.) 2008;14(11-12):665-74.
2008: Brian A McCarthy; Erin Boyle; Xue Ping Wang; Dorothy Guzowski; Santanu Paul; Rosa Catera; Joshua Trott; Joy (Xiao-Jie) Yan; Carlo M Croce; Rajendra N Damle; Sophia Yancopoulos; Bradley T Messmer; Martin Lesser; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).
Molecular medicine (Cambridge, Mass.) 2008;14(9-10):618-27.
2008: Laura Z Rassenti; Sonia Jain; Michael J Keating; William G Wierda; Michael R Grever; John C Byrd; Neil E Kay; Jennifer R Brown; John G Gribben; Donna S Neuberg; Feng He; Andrew W Greaves; Kanti Rai; Thomas Kipps
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
Blood 2008;112(5):1923-30.
2008: Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti Rai; Thomas Kipps
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Blood 2008;111(12):5446-56.
2008: Emanuela M Ghia; Sonia Jain; George F Widhopf; Laura Rassenti; Michael J Keating; William G Wierda; John G Gribben; Jennifer R Brown; Kanti Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Thomas Kipps
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.
Blood 2008;111(10):5101-8.
2008: Kanti Rai
The natural history of CLL and new prognostic markers.
Clinical advances in hematology & oncology : H&O 2008;6(5):4-5; quiz 10-2.
2008: Matthew Kaufman; Kanti Rai
Alemtuzumab in the up-front setting.
Therapeutics and clinical risk management 2008;4(2):459-64.
2008: George F Widhopf; Craig J Goldberg; Traci L Toy; Laura Rassenti; William G Wierda; John C Byrd; Michael J Keating; John G Gribben; Kanti Rai; Thomas Kipps
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
Blood 2008;111(6):3137-44.
2007: Rajendra N Damle; Sonal Temburni; Carlo Calissano; Sophia Yancopoulos; Taraneh Banapour; Cristina P Sison; Steven Allen; Kanti Rai; Nicholas Chiorazzi
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Blood 2007;110(9):3352-9.
2007: Kanti Rai
Introduction: Chronic lymphocytic leukemia in perspective.
Best practice & research. Clinical haematology 2007;20(3):363-5.
2007: John C Byrd; Susan O'Brien; Ian W Flinn; Thomas Kipps; Mark Weiss; Kanti Rai; Thomas S Lin; James Woodworth; Dee Wynne; Jennifer Reid; Arturo Molina; Bryan Leigh; Sarah Harris
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4448-55.
2007: Tomer T Levin; Yuelin Li; John H Riskind; Kanti Rai
Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort.
General hospital psychiatry 2007;29(3):251-6.
2007: Kanti Rai
Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapy.
Experimental hematology 2007;35(4 Suppl 1):134-6.
2007: Nicholas Dainiak; Kanti Rai; Arland Carsten; Ludwig Feinendegen
Eugene P. Cronkite--The man and his science.
Experimental hematology 2007;35(4 Suppl 1):5-7.
2007: Susan O'Brien; Joseph O Moore; Thomas E Boyd; Loree Larratt; Aleksander Skotnicki; Benjamin Koziner; Asher Chanan-Khan; John F Seymour; R Gregory Bociek; Steven Z Pavletic; Kanti Rai
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1114-20.
2006: Fabio Ghiotto; Franco Fais; Emilia Albesiano; Cristina P Sison; Angelo Valetto; Gianluca Gaidano; Janine Reinhardt; Jonathan E Kolitz; Kanti Rai; Steven Allen; Manlio Ferrarini; Nicholas Chiorazzi
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.
Molecular medicine (Cambridge, Mass.) 2006;12(11-12):300-8.
2006: Neil E Kay; Kanti Rai; Susan O'Brien
Chronic lymphocytic leukemia: current and emerging treatment approaches.
Clinical advances in hematology & oncology : H&O 2006;4(11 Suppl 22):1-10; quiz 11-2.
2006: Stefan Faderl; Kanti Rai; John Gribben; John C Byrd; Ian W Flinn; Susan O'Brien; Shihong Sheng; Dixie Esseltine; Michael J Keating
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Cancer 2006;107(5):916-24.
2006: Kanti Rai
Novel therapeutic strategies with alemtuzumab for chronic lymphocytic leukemia.
Seminars in oncology 2006;33(2 Suppl 5):S15-22.
2006: Jacques-Louis Binet; Federico Caligaris-Cappio; Daniel Catovsky; Bruce D Cheson; Tom Davis; Guillaume Dighiero; Hartmut Döhner; Michael Hallek; Peter Hillmen; Michael Keating; Emili Montserrat; Thomas Kipps; Kanti Rai
Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.
Blood 2006;107(3):859-61.
2005: Stefan Faderl; Steven Coutré; John C Byrd; Claire Dearden; A Denes; Martin J S Dyer; S A Gregory; J G Gribben; Peter Hillmen; Michael Keating; S Rosen; P Venugopal; Kanti Rai
The evolving role of alemtuzumab in management of patients with CLL.
Leukemia 2005;19(12):2147-52.
2005: Ian W Flinn; John C Byrd; Nancy Bartlett; Thomas Kipps; John Gribben; Deborah Thomas; Richard A Larson; Kanti Rai; Rosemary Petric; Jose Ramon-Suerez; Janice Gabrilove; Michael R Grever
Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity.
Leukemia research 2005;29(11):1253-7.
2005: Susan M O'Brien; Charles C Cunningham; Anatoly Golenkov; Anna G Turkina; steven novick; Kanti Rai
Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7697-702.
2005: Michael J Keating; Kanti Rai; William G Wierda
Evolution of treatment strategies in chronic lymphocytic leukemia. Part 2 of a 3-Part series: Advances in the treatment of hematologic malignancies.
Clinical advances in hematology & oncology : H&O 2005;3(8):1-10; quiz 11-2.
2005: Shahid Ahmed; Rabia K Shahid; Rola Rimawi; Anita K Siddiqui; Leonard Rossoff; Cristina P Sison; Harry Steinberg; Kanti Rai
Malignant pleural effusions in lymphoproliferative disorders.
Leukemia & lymphoma 2005;46(7):1039-44.
2005: John C Byrd; Bercedis L Peterson; Janice Gabrilove; Olatoyosi Odenike; Michael R Grever; Kanti Rai; Richard A Larson
Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4176-81.
2005: Bradley T Messmer; Davorka Messmer; Steven Allen; Jonathan E Kolitz; Prasad Kudalkar; Denise Cesar; Elizabeth J Murphy; Prasad R K Koduru; Manlio Ferrarini; Simona Zupo; Giovanna Cutrona; Rajendra N Damle; Tarun Wasil; Kanti Rai; Marc K Hellerstein; Nicholas Chiorazzi
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.
The Journal of clinical investigation 2005;115(3):755-64.
2005: Nicholas Chiorazzi; Kanti Rai; Manlio Ferrarini
Chronic lymphocytic leukemia.
The New England journal of medicine 2005;352(8):804-15.
2005: John C Byrd; Kanti Rai; Bercedis L Peterson; Frederick R Appelbaum; Vicki A Morrison; Jonathan E Kolitz; Lois Shepherd; John D Hines; Charles Alan Schiffer; Richard A Larson
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.
Blood 2005;105(1):49-53.
2004: Laura Rassenti; Lang Huynh; Tracy L Toy; Liguang Chen; Michael J Keating; John G Gribben; Donna Neuberg; Ian W Flinn; Kanti Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Arthur Weiss; Thomas Kipps
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
The New England journal of medicine 2004;351(9):893-901.
2004: Bradley T Messmer; Emilia Albesiano; Dimitar G Efremov; Fabio Ghiotto; Steven Allen; Jonathan E Kolitz; Robin Foa; Rajendra N Damle; Franco Fais; Davorka Messmer; Kanti Rai; Manlio Ferrarini; Nicholas Chiorazzi
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia.
The Journal of experimental medicine 2004;200(4):519-25.
2004: Kanti Rai; Tarun Wasil; Uzma Iqbal; Nancy Driscoll; Dilip Patel; Dale Janson; Bhoomi Mehrotra
Clinical staging and prognostic markers in chronic lymphocytic leukemia.
Hematology/oncology clinics of North America 2004;18(4):795-805, vii.
2004: Davorka Messmer; Gloria Telusma; Tarun Wasil; Bradley T Messmer; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.
Molecular medicine (Cambridge, Mass.) 2004;10(7-12):96-103.
2004: Kanti Rai
Exciting new developments in chronic lymphocytic leukemia: an introduction and an editorial.
Seminars in hematology 2004;41(3):189-90.
2004: Shahid Ahmed; Steven J Kussick; Anita K Siddiqui; Tawfiqul Bhuiya; Arfa Khan; Stephen Sarewitz; Harry Steinberg; Cristina P Sison; Kanti Rai
Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease.
European journal of cancer (Oxford, England : 1990) 2004;40(9):1320-6.
2004: Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven Allen; Jonathan E Kolitz; Kanti Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.
The Journal of clinical investigation 2004;113(7):1008-16.
2004: Michael Keating; Steven Coutré; Kanti Rai; Anders Osterborg; Stefan Faderl; Ben Kennedy; Tom Kipps; Gerald P Bodey; John C Byrd; Steven Rosen; Claire Dearden; Martin J S Dyer; Peter Hillmen
Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia.
Clinical lymphoma 2004;4(4):220-7.
2004: Tarun Wasil; Kanti Rai; Bhoomi Mehrotra
The role of monoclonal antibodies in stem cell transplantation.
Seminars in oncology 2004;31(1):83-9.
2004: Rajendra N Damle; Franak M Batliwalla; Fabio Ghiotto; Angelo Valetto; Emilia Albesiano; Cristina P Sison; Steven Allen; Jonathan E Kolitz; Vincent P Vinciguerra; Prasad Kudalkar; Tarun Wasil; Kanti Rai; Manlio Ferrarini; Peter K Gregersen; Nicholas Chiorazzi
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.
Blood 2004;103(2):375-82.
2004: William P Schiemann; Diana Rotzer; Walther Pfeifer; Edi Levi; Kanti Rai; Petra Knaus; Marshall E Kadin
Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
Cancer detection and prevention 2004;28(1):57-64.
2003: Shahid Ahmed; Anita K Siddiqui; Leonard Rossoff; Cristina P Sison; Kanti Rai
Pulmonary complications in chronic lymphocytic leukemia.
Cancer 2003;98(9):1912-7.
2003: Emilia Albesiano; Bradley T Messmer; Rajendra N Damle; Steven Allen; Kanti Rai; Nicholas Chiorazzi
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.
Blood 2003;102(9):3333-9.
2003: Kanti Rai; Nicholas Chiorazzi
Determining the clinical course and outcome in chronic lymphocytic leukemia.
The New England journal of medicine 2003;348(18):1797-9.
2003: Shahid Ahmed; Kanti Rai
Interferon in the treatment of hairy-cell leukemia.
Best practice & research. Clinical haematology 2003;16(1):69-81.
2003: Michael J Keating; Nicholas Chiorazzi; Bradley T Messmer; Rajendra N Damle; Steven Allen; Kanti Rai; Manlio Ferrarini; Thomas Kipps
Biology and treatment of chronic lymphocytic leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():153-75.
2003: John C Byrd; Bercedis L Peterson; Vicki A Morrison; Kathleen Park; Robert Jacobson; Eva Hoke; James W Vardiman; Kanti Rai; Charles Alan Schiffer; Richard A Larson
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
Blood 2003;101(1):6-14.
2002: Liguang Chen; George F Widhopf; Lang Huynh; Laura Rassenti; Kanti Rai; Arthur Weiss; Thomas Kipps
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Blood 2002;100(13):4609-14.
2002: George A Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Shashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(24):15524-9.
2002: N Gupta; S Kavuru; Dilip Patel; Dale Janson; N Driscoll; S Ahmed; Kanti Rai
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Leukemia 2002;16(10):2092-5.
2002: Kanti Rai; C E Freter; R J Mercier; M R Cooper; B S Mitchell; E A Stadtmauer; P Santábarbara; B Wacker; Lee R Brettman
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18):3891-7.
2002: Vicki A Morrison; Kanti Rai; Bercedis L Peterson; Jonathan E Kolitz; Laurence Elias; Frederick R Appelbaum; John D Hines; Lois Shepherd; Richard A Larson; Charles Alan Schiffer
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18):3878-84.
2002: Carmela Gurrieri; Peter McGuire; Hong Zan; Joy (Xiao-Jie) Yan; Andrea Cerutti; Emilia Albesiano; Steven Allen; Vincent P Vinciguerra; Kanti Rai; Manlio Ferrarini; Paolo Casali; Nicholas Chiorazzi
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.
The Journal of experimental medicine 2002;196(5):629-39.
2002: Kanti Rai
Campath-1H for chronic lymphocytic leukemia.
Clinical lymphoma 2002;3(2):73-4.
2002: Robert E Martell; Bercedis L Peterson; Harvey Jay Cohen; William P Petros; Kanti Rai; Vicki A Morrison; Laurence Elias; Lois Shepherd; John Hines; Richard A Larson; Charles Alan Schiffer; Herbert I Hurwitz
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Cancer chemotherapy and pharmacology 2002;50(1):37-45.
2002: Rajendra N Damle; Fabio Ghiotto; Angelo Valetto; Emilia Albesiano; Franco Fais; Joy (Xiao-Jie) Yan; Cristina P Sison; Steven Allen; Jonathan E Kolitz; Philip Schulman; Vincent P Vinciguerra; Petra Budde; Jurgen Frey; Kanti Rai; Manlio Ferrarini; Nicholas Chiorazzi
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.
Blood 2002;99(11):4087-93.
2002: Michael J Keating; Ian W Flinn; Vinay Jain; Jacques-Louis Binet; Peter Hillmen; John Byrd; Maher Albitar; Lee R Brettman; Pedro Santabarbara; Bret Wacker; Kanti Rai
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.
Blood 2002;99(10):3554-61.
2002: Shahid Ahmed; Anita K Siddiqui; Kanti Rai
Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma.
Cancer investigation 2002;20(7-8):1059-68.
2002: Kanti Rai; Michael Hallek
Future prospects for alemtuzumab (MabCampath).
Medical oncology (Northwood, London, England) 2002;19 Suppl():S57-63.
2002: Heinz Ludwig; Kanti Rai; Joan Blade; Franco Dammacco; Laurent Degos; Loretta Itri; Robert Kyle; Vicenzo Liso; Timothy James Littlewood; Franco Mandelli; Giovanna Meloni; Stefano Molica; Anders Osterborg; Gerassimos A Pangalis; Jesús San Miguel; Barbara Schmitt; Dimitrios Voliotis
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(3):121-30.
2002: Michael J Keating; B Cazin; Steven Coutré; R Birhiray; Tibor J Kovacsovics; W Langer; B Leber; T Maughan; Kanti Rai; Geir Tjønnfjord; M Bekradda; M Itzhaki; P Hérait
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):205-13.
2001: Vicki A Morrison; Kanti Rai; Bercedis L Peterson; Jonathan E Kolitz; Laurence Elias; Frederick R Appelbaum; John D Hines; Lois Shepherd; Robert E Martell; Richard A Larson; Charles Alan Schiffer
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(16):3611-21.
2001: Kanti Rai; H Döhner; M J Keating; E Montserrat
Chronic lymphocytic leukemia: case-based session.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2001;():140-56.
2001: Bernard J Poiesz; L D Papsidero; G Ehrlich; M Sherman; Syamalima Dube; M Poiesz; K Dillon; F W Ruscetti; Dennis J Slamon; C Fang; A Williams; D Duggan; J Glaser; A Gottlieb; Jack Goldberg; L Ratner; P Phillips; T Han; Alvin E Friedman-Kien; F Siegal; Kanti Rai; A Sawitsky; L W Sheremata; H Dosik; C Cunningham; R Montagna
Prevalence of HTLV-I-associated T-cell lymphoma.
American journal of hematology 2001;66(1):32-8.
2000: Kanti Rai; Bercedis L Peterson; Frederick R Appelbaum; Jonathan E Kolitz; Laurence Elias; Lois Shepherd; John Hines; G A Threatte; Richard A Larson; B D Cheson; Charles Alan Schiffer
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
The New England journal of medicine 2000;343(24):1750-7.
2000: Ian W Flinn; Kenneth J Kopecky; M K Foucar; D Head; John M Bennett; R Hutchison; W Corbett; Peter A Cassileth; Thomas M Habermann; H Golomb; Kanti Rai; E Eisenhauer; F Appelbaum; B Cheson; Michael R Grever
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
Blood 2000;96(9):2981-6.
2000: John C Byrd; Jamie K Waselenko; M Keating; Kanti Rai; Michael R Grever
Novel therapies for chronic lymphocytic leukemia in the 21st century.
Seminars in oncology 2000;27(5):587-97.
2000: J C Byrd; Kanti Rai
What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
Seminars in oncology 2000;27(4):xii-xv; discussion xv-xvi.
2000: Rajendra N Damle; Franco Fais; Fabio Ghiotto; Angelo Valetto; Emilia Albesiano; Tarun Wasil; Franak M Batliwalla; Steven Allen; Philip Schulman; Vincent P Vinciguerra; Kanti Rai; Peter K Gregersen; Manlio Ferrarini; Nicholas Chiorazzi
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation.
Current topics in microbiology and immunology 2000;252():285-92.
1999: Kanti Rai
Future strategies toward the cure of indolent B-cell malignancies. New biologic therapies.
Seminars in hematology 1999;36(4 Suppl 5):12-7.
1999: Rajendra N Damle; Tarun Wasil; Franco Fais; Fabio Ghiotto; Angelo Valetto; Steven Allen; A Buchbinder; Daniel R Budman; K Dittmar; Jonathan E Kolitz; Stuart M Lichtman; Philip Schulman; Vincent P Vinciguerra; Kanti Rai; Manlio Ferrarini; Nicholas Chiorazzi
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
Blood 1999;94(6):1840-7.
1999: Robert Peter Gale; RE Park; RW Dubois; GP Herzig; WG Hocking; mary m horowitz; A Keating; Sanford J. Kempin; Charles Linker; Charles Alan Schiffer; PH Wiernik; DJ Weisdorf; Kanti Rai
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.
Leukemia research 1999;23(9):817-26.
1999: Robert Peter Gale; RE Park; RW Dubois; GP Herzig; WG Hocking; mary m horowitz; A Keating; Sanford J. Kempin; Charles Linker; Charles Alan Schiffer; PH Wiernik; DJ Weisdorf; Kanti Rai
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.
Leukemia research 1999;23(8):709-18.
1999: Kanti Rai
Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment.
Haematologica 1999;84 Suppl EHA-4():94-5.
1999: Mark Hoffman; J C Xu; M Lesser; Kanti Rai
Cytotoxicity of 2-chlorodeoxadenosine (cladribine, 2-cdA) in combination with other chemotherapy drugs against two lymphoma cell lines.
Leukemia & lymphoma 1999;33(1-2):141-5.
1998: Robert Peter Gale; RE Park; RW Dubois; GP Herzig; WG Hocking; mary m horowitz; A Keating; Sanford J. Kempin; Charles Linker; Charles Alan Schiffer; PH Wiernik; DJ Weisdorf; Kanti Rai
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.
Leukemia research 1998;22(11):973-81.
1998: Franco Fais; Fabio Ghiotto; S Hashimoto; B Sellars; Angelo Valetto; Steven Allen; Philip Schulman; Vincent P Vinciguerra; Kanti Rai; Laura Rassenti; Thomas Kipps; Guillaume Dighiero; Harry Schroeder; Manlio Ferrarini; Nicholas Chiorazzi
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
The Journal of clinical investigation 1998;102(8):1515-25.
1998: Kanti Rai
Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Seminars in oncology 1998;25(3 Suppl 7):19-22.
1998: Shinichi Kitada; J Andersen; S Akar; Juan M Zapata; S Takayama; Stan Krajewski; Hong-Gang Wang; X Zhang; Florencia Bullrich; C M Croce; Kanti Rai; J Hines; John C Reed
Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.
Blood 1998;91(9):3379-89.
1998: John C Byrd; Kanti Rai; Edward A Sausville; Michael R Grever
Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals.
Seminars in oncology 1998;25(1):65-74.
1997: Kanti Rai
Chronic lymphocytic leukemia in the elderly population.
Clinics in geriatric medicine 1997;13(2):245-9.
1997: Mark Hoffman; Dale Janson; E Rose; Kanti Rai
Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1138-42.
1996: Franco Fais; B Sellars; Fabio Ghiotto; Joy (Xiao-Jie) Yan; Mariella Dono; Steven Allen; Daniel R Budman; K Dittmar; Jonathan E Kolitz; Stuart M Lichtman; Philip Schulman; M Schuster; Vincent P Vinciguerra; Kanti Rai; F K Stevenson; Peter K Gregersen; Manlio Ferrarini; Nicholas Chiorazzi
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
The Journal of clinical investigation 1996;98(7):1659-66.
1996: C L Alter; Stewart Fleishman; Alice B Kornblith; Jimmie C Holland; D Biano; R Levenson; V Vinciguerra; Kanti Rai
Supportive telephone intervention for patients receiving chemotherapy. A pilot study.
Psychosomatics 1996;37(5):425-31.
1996: Bruce D Cheson; J M Bennett; Michael R Grever; N Kay; M J Keating; S O'Brien; Kanti Rai
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.
Blood 1996;87(12):4990-7.
1996: Ronald B Gartenhaus; Mark Hoffman; Alexander Fuchs; H Billet; Ping Wang; P Gentile; Kanti Rai
Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.
Leukemia & lymphoma 1996;22(1-2):97-101, follow.186, color plate IX.
1996: M Soni; J Brody; Steven Allen; Philip Schulman; Jonathan E Kolitz; Kanti Rai; J D Broome; Prasad R K Koduru
Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
Leukemia 1996;10(4):619-23.
1996: Ronald B Gartenhaus; Ping Wang; Mark Hoffman; D Janson; Kanti Rai
The induction of p53 and WAF1/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosine.
Journal of molecular medicine (Berlin, Germany) 1996;74(3):143-7.
1996: Ronald B Gartenhaus; Michael M Johns; Ping Wang; Kanti Rai; David Sidransky
Mutator phenotype in a subset of chronic lymphocytic leukemia.
Blood 1996;87(1):38-41.
1995: Kanti Rai; F Davey; B Peterson; Charles Alan Schiffer; R T Silver; Howard Ozer; H Golomb; Clara D Bloomfield
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
Leukemia 1995;9(7):1116-20.
1995: Mark Hoffman; Elsa Valderrama; Alexander Fuchs; M Friedman; Kanti Rai
Leukemic meningitis in B-cell prolymphocytic leukemia. A clinical, pathologic, and ultrastructural case study and a review of the literature.
Cancer 1995;75(5):1100-3.
1994: F P Siegal; M Shodell; K Shah; D Drake; Mark Hoffman; A Sawitsky; D Janson; Patricia Fitzgerald-Bocarsly; Kanti Rai
Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.
Leukemia 1994;8(9):1474-9.
1994: R P Gale; F Caligaris-Cappio; G Dighiero; M Keating; E Montserrat; Kanti Rai
Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.
Leukemia 1994;8(9):1610-4.
1994: A Z Safferman; Jeffrey A Lieberman; D Zeman; S Szymanski; A V Pisciotta; Kanti Rai
Response to "Unrelated agranulocytosis in a patient taking clozapine".
Journal of clinical psychopharmacology 1994;14(3):211-2.
1994: Mark Hoffman; Martin S Tallman; David Hakimian; D Janson; D Hogan; D Variakogis; Timothy M Kuzel; L I Gordon; Kanti Rai
2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):788-92.
1994: E Montserrat; J L Binet; G Dighiero; R P Gale; G Juliusson; M Keating; Kanti Rai
Chronic lymphoproliferative disorders.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1994;Suppl():52-8.
1994: Kanti Rai
Response criteria with fludarabine therapy in chronic lymphocytic leukemia.
Blood 1994;83(3):875-6.
1994: Kanti Rai
Comparison of pentostatin and alpha interferon in splenectomized patients with active hairy cell leukemia: an intergroup study. Cancer and Leukemia Group B and South-West Oncology Group.
Leukemia & lymphoma 1994;14 Suppl 1():107-8.
1993: Kanti Rai
Progress in chronic lymphocytic leukaemia: a historical perspective.
Baillière's clinical haematology 1993;6(4):757-65.
1993: Howard Ozer; S L George; Charles Alan Schiffer; Kathleen W Rao; P N Rao; D H Wurster-Hill; D D Arthur; B Powell; A Gottlieb; B A Peterson; Kanti Rai; J R Testa; M LeBeau; R Tantravahi; C D Bloomfield
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.
Blood 1993;82(10):2975-84.
1993: A Z Safferman; Jeffrey A Lieberman; D Zeman; S Szymanski; A V Pisciotta; Kanti Rai
Unrelated agranulocytosis in a patient taking clozapine.
Journal of clinical psychopharmacology 1993;13(3):218-9.
1992: Emili Montserrat; J L Binet; D Catovsky; G Dighiero; R P Gale; Kanti Rai; Ciril Rozman
5th International Workshop on Chronic Lymphocytic Leukemia.
Leukemia research 1992;16(6-7):717-20.
1990: Frances Santiago-Schwarz; C Panagiotopoulos; A Sawitsky; Kanti Rai
Distinct characteristics of lymphokine-activated killer (LAK) cells derived from patients with B-cell chronic lymphocytic leukemia (B-CLL). A factor in B-CLL serum promotes natural killer cell-like LAK cell growth.
Blood 1990;76(7):1355-60.
1990: K A Foon; Kanti Rai; R P Gale
Chronic lymphocytic leukemia: new insights into biology and therapy.
Annals of internal medicine 1990;113(7):525-39.
1990: S B Wormsley; S M Baird; N Gadol; Kanti Rai; RE Sobol
Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
Blood 1990;76(1):123-30.
1990: Kanti Rai; T Han
Prognostic factors and clinical staging in chronic lymphocytic leukemia.
Hematology/oncology clinics of North America 1990;4(2):447-56.
1990: T Han; Kanti Rai
Management of chronic lymphocytic leukemia.
Hematology/oncology clinics of North America 1990;4(2):431-45.
1989: Bruce D Cheson; J M Bennett; Kanti Rai; Michael R Grever; N E Kay; M M Oken; Charles Alan Schiffer; M J Keating; D H Boldt; Sanford J. Kempin
Chronic lymphocytic leukemia: recommendations.
Annals of internal medicine 1989;110(8):664-5.
1989: Harvey D Preisler; K Anderson; Kanti Rai; J Cuttner; J Yates; E DuPre; James F Holland
The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years.
British journal of haematology 1989;71(2):189-94.
1988: Bruce D Cheson; J M Bennett; Kanti Rai; Michael R Grever; N E Kay; Charles Alan Schiffer; M M Oken; M J Keating; D H Boldt; Sanford J. Kempin
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
American journal of hematology 1988;29(3):152-63.
1988: Jeffrey A Lieberman; C A Johns; John M Kane; Kanti Rai; A V Pisciotta; B L Saltz; A Howard
Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
The Journal of clinical psychiatry 1988;49(7):271-7.
1988: C Shustik; R Mick; R Silver; A Sawitsky; Kanti Rai; L Shapiro
Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation.
Hematological oncology 1988;6(1):7-12.
1988: S B Wormsley; Kanti Rai; R P Gale
Analysis of treatment response in chronic lymphocytic leukemia: new approaches.
Nouvelle revue française d'hématologie 1988;30(5-6):413-7.
1987: Kanti Rai; E Montserrat
Prognostic factors in chronic lymphocytic leukemia.
Seminars in hematology 1987;24(4):252-6.
1987: Robert Peter Gale; Kanti Rai
New insights into a chronic lymphocytic leukemia.
Leukemia 1987;1(9):677-9.
1987: R J Mayer; Charles Alan Schiffer; B A Peterson; D R Budman; R T Silver; Kanti Rai; G G Cornwell; R R Ellison; M Maguire; D T Berg
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
Seminars in oncology 1987;14(2 Suppl 1):25-31.
1987: Kanti Rai; J Cuttner; James F Holland; R Davis; R Mayer; O R McIntyre; Harvey D Preisler; J Yates
Therapeutic strategies in acute myelocytic leukemia: a status report of the experience of CALGB. Cancer and Leukemia Group B.
Haematology and blood transfusion 1987;30():31-4.
1987: Kanti Rai; A Sawitsky
A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia.
Blood cells 1987;12(2):327-38.
1986: W R Vogler; Harvey D Preisler; E F Winton; A J Gottlieb; Jack Goldberg; J Brennan; H Grunwald; Kanti Rai; George Browman; K B Miller
Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.
Cancer treatment reports 1986;70(4):455-9.
1985: S Zucker; K Mehling; Kanti Rai
Plasminogen-dependent fibrinolytic activity in normal human lymphocytes: diminished lymphocyte plasminogen activator in chronic lymphocytic leukemia.
American journal of hematology 1985;19(4):373-86.
1985: R J Mayer; Charles Alan Schiffer; B A Peterson; R T Silver; G G Cornwell; O R McIntyre; Kanti Rai; D R Budman; R R Ellison; M Maguire
Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I study.
Seminars in oncology 1985;12(2 Suppl 3):84-90.
1985: Jack Goldberg; H Grunwald; W R Vogler; E Winton; George Browman; I Walker; A Benger; K B Miller; Kanti Rai; A J Gottlieb
Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup study.
American journal of hematology 1985;19(2):167-76.
1985: Kanti Rai; E P Cronkite; A Sawitsky; P Chandra; J Steinberg
Studies in chronic lymphocytic leukemia: blood lymphocyte surface characteristics and immunologic functional status of patients and correlation with clinical stage.
Annals of the New York Academy of Sciences 1985;459():336-43.
1984: G X Qian; S M Fu; D L Solanki; Kanti Rai
Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(6):3396-400.
1984: Harvey D Preisler; Joshua Epstein; M Barcos; R Priore; Azra Raza; George Browman; R Vogler; E Winton; H Grunwald; Kanti Rai
Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
British journal of haematology 1984;58(1):19-32.
1984: Kanti Rai; A Sawitsky; K Jagathambal; W Gartenhaus; E Phillips
Chronic lymphocytic leukemia.
The Medical clinics of North America 1984;68(3):697-711.
1982: R J Kanter; Kanti Rai; F Muniz; B Michael; J Balkon; A Sawitsky
Intracellular zinc in chronic lymphocytic leukemia.
Clinical immunology and immunopathology 1982;24(1):26-32.
1981: Kanti Rai; James F Holland; O J Glidewell; V Weinberg; K Brunner; J P Obrecht; Harvey D Preisler; I W Nawabi; D Prager; RW Carey; M R Cooper; F Haurani; J L Hutchison; R T Silver; G Falkson; P Wiernik; H C Hoagland; Clara D Bloomfield; G W James; A Gottlieb; S V Ramanan; J Blom; N I Nissen; A Bank; R R Ellison; Faith H Kung; P Henry; O R McIntyre; S K Kaan
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.
Blood 1981;58(6):1203-12.
1980: M D Lipshutz; R Mir; Kanti Rai; A Sawitsky
Bone marrow biopsy and clinical staging in chronic lymphocytic leukemia.
Cancer 1980;46(6):1422-7.
1980: M Coleman; R T Silver; T F Pajak; F Cavalli; Kanti Rai; J E Kostinas; O Glidewell; James F Holland
Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studies.
Blood 1980;55(1):29-36.
1979: H O Kerpen; J G Bhat; R Kantor; B Gauthier; Kanti Rai; R G Schacht; D S Baldwin
Lymphocyte subpopulations in minimal change nephrotic syndrome.
Clinical immunology and immunopathology 1979;14(1):130-6.
1979: P Chandra; A Sawitsky; A D Chanana; G Chikkappa; S H Cohn; Kanti Rai; E P Cronkite
Correlation of total body potassium and leukemic cell mass in patients with chronic lymphocytic leukemia.
Blood 1979;53(4):594-603.
1979: R J Kanter; I A Freiberger; Kanti Rai; A Sawitsky
Lymphocyte populations with 5'-nucleotidase in chronic lymphocytic leukemia.
Clinical immunology and immunopathology 1979;12(3):351-7.
1979: Nicholas Chiorazzi; S M Fu; G Montazeri; H G Kunkel; Kanti Rai; T Gee
T cell helper defect in patients with chronic lymphocytic leukemia.
Journal of immunology (Baltimore, Md. : 1950) 1979;122(3):1087-90.
1979: E S Henderson; C Scharlau; M R Cooper; F I Haurani; R T Silver; K Brunner; R W Carey; G Falkson; J Blom; I V Nawabi; A S Levine; A Bank; J Cuttner; G G Cornwell; P Henry; N I Nissen; P H Wiernik; L Leone; H Wohl; Kanti Rai; G W James; V Weinberg; O Glidewell; J F Holland
Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113.
Leukemia research 1979;3(6):395-407.
1978: R T Silver; A Sawitsky; Kanti Rai; Jimmie C Holland; O Glidewell
Guidelines for protocol studies in chronic lymphocytic leukemia.
American journal of hematology 1978;4(4):343-58.
1977: A Sawitsky; Kanti Rai; O Glidewell; R T Silver
Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia.
Blood 1977;50(6):1049-59.
1976: A Sawitsky; Kanti Rai; I Aral; R T Silver; A S Glicksman; R W Carey; S Scialla; C J Cornell; B Seligman; L Shapiro
Mediastinal irradiation for chronic lymphocytic leukemia.
The American journal of medicine 1976;61(6):892-6.
1976: J F Holland; O Glidewell; R R Ellison; R W Corey; J Schwartz; H J Wallace; H C Hoagland; P Wiernik; Kanti Rai; J G Bekesi; J Cuttner
Acute myelocytic leukemia.
Archives of internal medicine 1976;136(12):1377-81.
1976: A D Chanana; E P Cronkite; Kanti Rai
The role of extracorporeal irradiation of blood in treatment of leukemia.
International journal of radiation oncology, biology, physics 1976;1(5-6):539-48.
1975: G L Gulliani; A D Chanana; E P Cronkite; D D Joel; J Laissue; Kanti Rai
Survival of chromium-51-labeled autologous and homologous erythrocytes in goats.
American journal of veterinary research 1975;36(10):1469-71.
1975: Kanti Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Clinical staging of chronic lymphocytic leukemia.
Blood 1975;46(2):219-34.
1974: S M Fu; R J Winchester; Kanti Rai; H G Kunkel
Hairy cell leukemia: proliferation of a cell with phagocytic and B-lymphocyte properties.
Scandinavian journal of immunology 1974;3(6):847-51.
1972: W H Cheung; Kanti Rai; A Sawitsky
Characteristics of cell proliferation in acute leukemia.
Cancer research 1972;32(5):939-42.
1971: Kanti Rai; A D Chanana; E P Cronkite; D D Joel; J B Stevens
Studies on lymphocytes 18. Mechanism of lymphocytosis induced by supernatant fluids of Bordetella pertussis cultures.
Blood 1971;38(1):49-59.
1971: Kanti Rai; A D Chanana; E P Cronkite; G L Gulliani; D D Joel
Studies on the leukocytopenia due to acute effects of supernatant fluids of Bordetella pertussis cultures.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1971;136(2):433-8.
1970: C Ruchti; H Cottier; E P Cronkite; C R Jansen; Kanti Rai
Studies on lymphocytes. XVII. Differential lymphocyte depletion in lymphoreticular organs of the calf during continuous extracorporeal x-irradiation of the circulating blood.
Cell and tissue kinetics 1970;3(3):301-15.
1970: S Okuyama; R B Aronson; A D Chanana; E P Cronkite; Kanti Rai; L M Schiffer
Attempts at isolation of lymphocytosis-producing factor from supernatant fluids of Bordetella pertussis cultures.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1970;133(2):723-7.
1970: H Schaer; R Schindler; B Roos; H Cottier; Kanti Rai; E P Cronkite
[Replacement rate of lymphocytes in the peripheral blood and in lymph nodes of rats. An autoradiographic study using repeated injections of thymidine-3H over a prolonged period of time].
Zeitschrift für Zellforschung und mikroskopische Anatomie (Vienna, Austria : 1948) 1970;111(1):75-89.
1969: L M Schiffer; A D Chanana; E P Cronkite; M L Greenberg; S Okuyama; Kanti Rai; V S Robertson; P A Stryckmans; P C Vincent
Lymphocyte kinetics in chronic lymphocytic leukaemia (CLL) studied by ECIB.
British journal of haematology 1969;17(4):408.
1968: L M Schiffer; A D Chanana; E P Cronkite; M L Greenberg; Kanti Rai; P Stryckmans; P Vincent
[Extracorporeal radiation of the blood in chronic lymphocytic leukemia].
Nouvelle revue française d'hématologie 1968;8(5):691-700.
1968: A D Chanana; E P Cronkite; M L Greenberg; Kanti Rai; L M Schiffer; P A Stryckmans; P C Vincent
Experience with arteriovenous shunts in leukemic patients.
Archives of surgery (Chicago, Ill. : 1960) 1968;97(1):154-60.
1967: L Cunningham; H Cottier; E P Cronkite; C R Jansen; Kanti Rai; S Safier; H P Wagner
Studies on lymphocytes. 8. Short in vivo mitotic time of basophilic lymphoid cells in the thoracic duct of calves after simulated or effective extracorporeal irradiation of circulating blood.
Experimental cell research 1967;47(3):479-88.
1967: S Safier; H Cottier; E P Cronkite; C R Jansen; Kanti Rai; H P Wagner
Studies on lymphocytes. VI. Evidence showing different generation times for cytologically different lymphoid cell lines in the thoracic duct of the calf.
Blood 1967;30(3):301-10.
1967: H P Wagner; H Cottier; E P Cronkite; L Cunningham; C R Jansen; Kanti Rai
Studies on lymphocytes. V. Short in vivo DNA synthesis and generation time of lymphoid cells in the calf thoracic duct after simulated or effective extracorporeal irradiation of circulating blood.
Experimental cell research 1967;46(2):441-51.
1964: H COTTIER; E P CRONKITE; C R JANSEN; Kanti Rai; S SINGER; C R SIPE
STUDIES ON LYMPHOCYTES. 3. EFFECTS OF EXTRACORPOREAL IRRADIATION OF THE CIRCULATING BLOOD UPON THE LYMPHORETICULAR ORGANS IN THE CALF.
Blood 1964;24():241-53.
1964: C R JANSEN; V P BOND; Kanti Rai; S W LIPPINCOTT
ABSCOPAL EFFECTS OF LOCALIZED IRRADIATION BY ACCELERATOR BEAMS.
Annals of the New York Academy of Sciences 1964;114():302-15.
1964: E P CRONKITE; C R JANSEN; H COTTIER; Kanti Rai; C R SIPE
LYMPHOCYTE PRODUCTION MEASURED BY EXTRACORPOREAL IRRADIATION, CANNULATION, AND LABELING TECHNIQUES.
Annals of the New York Academy of Sciences 1964;113():566-77.
1963: S W LIPPINCOTT; J E JESSEPH; C P BAKER; W G CALVO; C R JANSEN; Kanti Rai; V ALCOBER
EFFECTS OF HEAVY HIGH ENERGY CHARGED PARTICLES. II. PRIMARY ATYPICAL EPITHELIAL HYPERPLASIA IN MOUSE SKIN AFTER EXPOSURE TO 10 MEV PROTONS, 20 MEV DEUTERONS, OR 40 MEV ALPHA-PARTICLES.
Archives of pathology 1963;76():527-36.
1962: C R JANSEN; E P CRONKITE; G C MATHER; N O NIELSEN; Kanti Rai; E R ADAMIK; C R SIPE
Studies on lymphocytes. II. The production of lymphocytosis by intravenous heparin in calves.
Blood 1962;20():443-52.
1962: J GREENBERG; A SAWITSKY; L WEISFUSE; R N LEVY; Kanti Rai; H C DUDLEY
Therapy of multiple myeloma with radiotytrium (Y90).
The Journal of laboratory and clinical medicine 1962;59():898-904.
1962: J GREENBERG; A SAWITSKY; H C DUDLEY; R N LEVY; Kanti Rai
Therapy of polycythemia vera with radiotytrium (Y-90).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1962;3():18-25.